Accordingly, the BCR-ABL-mediated pathophysiological hyper-phosphorylation of LASP1 in CML disrupts normal regulation of CRKL and LASP1, which likely has implications on downstream BCR-ABL signaling. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.